| Product Code: ETC6921239 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Czech Republic NGS Services Market Overview |
3.1 Czech Republic Country Macro Economic Indicators |
3.2 Czech Republic NGS Services Market Revenues & Volume, 2021 & 2031F |
3.3 Czech Republic NGS Services Market - Industry Life Cycle |
3.4 Czech Republic NGS Services Market - Porter's Five Forces |
3.5 Czech Republic NGS Services Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Czech Republic NGS Services Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Czech Republic NGS Services Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.8 Czech Republic NGS Services Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Czech Republic NGS Services Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and precision healthcare solutions |
4.2.2 Technological advancements in next-generation sequencing (NGS) technologies |
4.2.3 Growing research and development activities in genomics and biomedical fields |
4.3 Market Restraints |
4.3.1 High initial setup costs and ongoing maintenance expenses for NGS services |
4.3.2 Lack of skilled professionals in the field of genomics and bioinformatics |
4.3.3 Regulatory challenges and data privacy concerns surrounding genomic data |
5 Czech Republic NGS Services Market Trends |
6 Czech Republic NGS Services Market, By Types |
6.1 Czech Republic NGS Services Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Czech Republic NGS Services Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Czech Republic NGS Services Market Revenues & Volume, By SBS, 2021- 2031F |
6.1.4 Czech Republic NGS Services Market Revenues & Volume, By Ion Semiconductor, 2021- 2031F |
6.1.5 Czech Republic NGS Services Market Revenues & Volume, By SBL, 2021- 2031F |
6.1.6 Czech Republic NGS Services Market Revenues & Volume, By Pyro-Sequencing, 2021- 2031F |
6.1.7 Czech Republic NGS Services Market Revenues & Volume, By SMRT, 2021- 2031F |
6.2 Czech Republic NGS Services Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Czech Republic NGS Services Market Revenues & Volume, By Research applications, 2021- 2031F |
6.2.3 Czech Republic NGS Services Market Revenues & Volume, By Clinical applications, 2021- 2031F |
6.2.4 Czech Republic NGS Services Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.2.5 Czech Republic NGS Services Market Revenues & Volume, By RNA-sequencing, 2021- 2031F |
6.2.6 Czech Republic NGS Services Market Revenues & Volume, By Targeted sequencing, 2021- 2031F |
6.2.7 Czech Republic NGS Services Market Revenues & Volume, By Exome sequencing, 2021- 2031F |
6.2.8 Czech Republic NGS Services Market Revenues & Volume, By Other, 2021- 2031F |
6.2.9 Czech Republic NGS Services Market Revenues & Volume, By Other, 2021- 2031F |
6.3 Czech Republic NGS Services Market, By Disease Type |
6.3.1 Overview and Analysis |
6.3.2 Czech Republic NGS Services Market Revenues & Volume, By Oncology, 2021- 2031F |
6.3.3 Czech Republic NGS Services Market Revenues & Volume, By Lung cancer, 2021- 2031F |
6.3.4 Czech Republic NGS Services Market Revenues & Volume, By Breast cancer, 2021- 2031F |
6.3.5 Czech Republic NGS Services Market Revenues & Volume, By Prostate cancer, 2021- 2031F |
6.3.6 Czech Republic NGS Services Market Revenues & Volume, By Colorectal cancer, 2021- 2031F |
6.3.7 Czech Republic NGS Services Market Revenues & Volume, By Other, 2021- 2031F |
6.4 Czech Republic NGS Services Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Czech Republic NGS Services Market Revenues & Volume, By Research centres, academic & government institutes, 2021- 2031F |
6.4.3 Czech Republic NGS Services Market Revenues & Volume, By Hospitals & clinics, 2021- 2031F |
6.4.4 Czech Republic NGS Services Market Revenues & Volume, By Pharmaceutical & biotechnology companies, 2021- 2031F |
6.4.5 Czech Republic NGS Services Market Revenues & Volume, By Others, 2021- 2031F |
7 Czech Republic NGS Services Market Import-Export Trade Statistics |
7.1 Czech Republic NGS Services Market Export to Major Countries |
7.2 Czech Republic NGS Services Market Imports from Major Countries |
8 Czech Republic NGS Services Market Key Performance Indicators |
8.1 Average turnaround time for NGS service delivery |
8.2 Rate of adoption of NGS technologies in healthcare institutions and research facilities |
8.3 Number of collaborations and partnerships between NGS service providers and biopharmaceutical companies |
8.4 Level of investment in RD for improving NGS technologies and services |
8.5 Customer satisfaction and feedback scores for NGS service providers in the Czech Republic |
9 Czech Republic NGS Services Market - Opportunity Assessment |
9.1 Czech Republic NGS Services Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Czech Republic NGS Services Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Czech Republic NGS Services Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.4 Czech Republic NGS Services Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Czech Republic NGS Services Market - Competitive Landscape |
10.1 Czech Republic NGS Services Market Revenue Share, By Companies, 2024 |
10.2 Czech Republic NGS Services Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here